Puma Biotechnology (PBYI) Other financing activities (2010 - 2024)
Puma Biotechnology (PBYI) posted Other financing activities of $150000.0 for Q3 2024, down 94.0% on a QoQ basis from $2.5 million in Q4 2022.
Puma Biotechnology (PBYI) Other financing activities (2010 - 2024) Analysis & Trends
Puma Biotechnology's Other financing activities history runs 11 years deep, the most recent figure standing at $150000.0 for Q3 2024.
- Quarterly Other financing activities changed N/A year-over-year to $150000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $150000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $130000.0, down 13.33% from the prior year.
- Other financing activities was $150000.0 for Q3 2024 at Puma Biotechnology, down from $2.5 million in the prior quarter.
- Across five years, Other financing activities topped out at $10.0 million in Q1 2022 and bottomed at -$45000.0 in Q4 2020.
- A 3-year average of $2.5 million and a median of $150000.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 43.42% in 2020, while the deepest fall reached 4400.0% in 2020.
- Puma Biotechnology's Other financing activities stood at -$45000.0 in 2020, then surged by 5655.56% to $2.5 million in 2022, then slumped by 94.0% to $150000.0 in 2024.
- Business Quant data shows PBYI's Other financing activities at $150000.0 in Q3 2024, $2.5 million in Q4 2022, and $10.0 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2020 | -45,000.00 |
| Dec 31, 2020 | -45,000.00 |
| Sep 30, 2020 | 43,000.00 |
| Sep 30, 2020 | 43,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Jun 30, 2019 | 194,000.00 |
| Jun 30, 2019 | 194,000.00 |
| Mar 31, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2018 | 501,000.00 |
| Dec 31, 2018 | 501,000.00 |